Korea

Shinhan Financial Group files its FY2021 Form 20-F to the SEC

SEOUL, South Korea, April 21, 2022 /PRNewswire/ -- Shinhan Financial Group (NYSE: SHG) (KRX: 055550) filed its Annual Report on Form 20-F for the year endedDecember 31, 2021 with the U.S. Securities and Exchange Commission (SEC) on April 20, 2022. The report is available at Shinhan Financial Group...

2022-04-21 15:31 2727

Samsung Biologics completes full acquisition of Samsung Bioepis

* Samsung Biologics has now fully acquired Samsung Bioepis, as a wholly owned subsidiary * First payment completed funded through paid-in capital * Accelerated growth expected in biosimilars and future novel therapeutics R&D INCHEON,South Korea, April 20, 2022  /PRNewswire/ -- Samsung Biologi...

2022-04-20 14:45 1922

Love Edellis, the representative brand of 'K-beauty and eco-friendly body mask pack,' participates in the '2022 Cosmoprof Worldwide Bologna Fair'

SEOUL, South Korea, April 19, 2022 /PRNewswire/ -- Love Edellis, a representative brand of body mask packs for all body parts from hair to toe, will participate in the 2022 Cosmoprof Worldwide Bologna Fair inItaly and officially start exploring the global market.

2022-04-20 09:50 1243

Kakao Brain Unveils Efficient Text-to-Image Generator, RQ-Transformer, on GitHub

* Doubled the sampling speed compared to company's 'minDALL-E' model * Achieved enhanced quality and faster sampling speed by configuring high-resolution images as low-resolution 3D tensors * Technology to be presented at global computer vision conference, CVPR 2022 SEOUL, South Korea , Apri...

2022-04-20 09:00 1416

Bridge Biotherapeutics Enters into an Exclusive License Agreement with Shaperon to Strengthen Its IPF Franchise

* The licensing deal includes an upfront payment of USD 1.63 million, and may reach up toUSD 24.4 million in milestone payments and royalties * By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive tre...

2022-04-19 09:19 1801

PABLO AIR Co.,Ltd. Announced as Finalist for AUVSI XCELLENCE Awards

* Awards ceremony to be held at AUVSI XPONENTIAL 2022 in Orlando, FL. INCHEON, South Korea, April 17, 2022 /PRNewswire/ -- South Korea-based drone service provider PABLO AIR, a member of Born2Global Centre, has been named as a finalist in the Enterprise of theXCELLENCE Awards by the Association ...

2022-04-18 10:09 2096

Samsung Electro-Mechanics develops 13 types of MLCC for automotive powertrains

*  MLCC for powertrains with guaranteed use at as high as 150℃ - Releases 13 types of automotive MLCCs in various sizes and capacitances - Plans to supply new products to global auto parts manufacturers * Samsung Electro-Mechanics Expands the lineup of automotive MLCCs to aggressively target th...

2022-04-13 09:30 1571

HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies to Expand Growth Initiative

* HanAll Biopharma and Daewoong Pharmaceutical invest in the broad potential of Turn Biotechnologies  * Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases SEOUL, South Korea ,April 12, 2022 /PRNewswire/ -- HanAll...

2022-04-13 08:00 1457

Bridge Biotherapeutics Presented the Preclinical Data of BBT-207 at the AACR Annual Meeting 2022

* The preclinical data supports the clinical development of BBT-207 for EGFR mutant NSCLC patients harboring C797S double mutations, as well as for those who are treatment-naïve * The company plans to submit an IND application to the US FDA in 2022 and looks forward to entering the Phase 1 st...

2022-04-13 06:00 959

/DISREGARD RELEASE: HanAll Biopharma and Daewoong Pharmaceutical/

We are advised by HanAll Biopharma and Daewoong Pharmaceutical that journalists and other readers should disregard the news release, "Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative", issued11-Apr-2022 over PR Newswire. ...

2022-04-12 15:34 1618

PharmAbcine Presents Updated Preclinical Data of Its Anti-VISTA Antibody Candidate at AACR 2022

DAEJEON, South Korea, April 11, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), aclinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company presented an updated preclinical data PMC-309, the Company's anti-VISTA ...

2022-04-11 20:00 742

Samyang Foods sponsors BTS PERMISSION TO DANCE ON STAGE - LAS VEGAS

- Part of global promotion campaign of K-spicy to commemorate the 10th anniversary of the launching Buldak SEOUL, South Korea, April 8, 2022 /PRNewswire/ -- Samyang Foods announced on April 8 that it will participate as the main sponsor of BTS PERMISSION TO DANCE ON STAGE –LAS VEGAS, commemorati...

2022-04-09 00:00 3606

OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate

* Identified knockdown of target genes for the NASH treatment candidate * Reduction of ALT and AST liver marker levels observed in monkey models * Company to present results at the 2022 Academic Symposium of the Korean Endocrine Society SUWON, South Korea, April 8, 2022 /PRNewswire/ -- OliX ...

2022-04-08 20:00 2948

LG Energy Solution Releases Preliminary Earnings for First Quarter 2022

SEOUL, South Korea, April 7, 2022 /PRNewswire/ -- LG Energy Solution (LGES; KRX: 373220) today announced its preliminary earnings results for the first quarter of 2022. LGES reported revenues of KRW 4.34 trillion, a decrease of 2.2% compared to the previous quarter. LG Energy Solution's first q...

2022-04-07 15:55 1818

LG Display Demonstrates OLED.EX's Evolutionary Experience at 2022 OLED Korea Conference

SEOUL, South Korea, April 6, 2022 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today thatLee Hyeon-woo, Senior Vice President and Head of Life Display Business Group at LG Display, gave a keynote speech under the theme of 'OLED, The Evolutionary Exp...

2022-04-07 12:16 1820

HitGen and UPPTHERA Extend PROTAC Research Collaboration after Hit Finding Success on Undruggable Targets

CHENGDU, China, April 6, 2022 /PRNewswire/ -- HitGen Inc. ("HitGen"), a Shanghai Stock Exchange STAR-listed company (ticker code 688222.SH), today announced that the company has successfully completed the multiple-target drug discovery research projects with UPPTHERA, a Korean pharmaceutical comp...

2022-04-06 22:30 2196

New Studies at AACR 2022 Highlight Lunit SCOPE's Immune Phenotyping Capabilities

* Lunit to present two abstracts about its AI-biomarker for immunotherapy, Lunit SCOPE IO * Lunit will deliver an oral presentation on its breakthrough study supporting the effectiveness of Lunit SCOPE IO as a prognostic biomarker for endometrial cancer SEOUL, South Korea, April 6, 2022 /PRNe...

2022-04-06 21:44 1887

LG Display's Gaming OLED Video Series Hits 100 Million Views

SEOUL, South Korea, April 4, 2022 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today that its three-part 'NO OLED. NO GAME.' video series is under the global limelight, hitting more than 100 million views on the Internet. By introducing the outstand...

2022-04-05 09:00 1989

Vieworks to Make Its Debut at AACR Annual Meeting 2022 with VISQUE InVivo Series

ANYANG, South Korea, April 4, 2022 /PRNewswire/ -- Vieworks will be showcasing its optical in vivo imaging systems at AACR Annual Meeting (April 10-13, booth 2308). VISQUE InVivo Art is Vieworks' premium preclinical optical imaging system for high-sensitivity fluorescent & bioluminescent imaging ...

2022-04-04 21:00 2043

NEW ID Brings BABY SHARK TV Channel to Newly Launched Spanish-Language Streamer ViX

* BABY SHARK TV Channel is now available on ViX, the AVOD tier of TelevisaUnivision's new global Spanish-language streaming service. * The leading FAST distributor of Asian content, NEW ID expands its partnership with the global entertainment company behind Baby Shark, The Pinkfong Company, t...

2022-04-01 21:00 2522
1 ... 67686970717273 ... 111

Week's Top Stories